Hans Van Houte Nurix Therapeutics, Inc. (NRIX) insider trading activity

NRIX Quotes by TradingView

Hans Van Houte is Chief Financial Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 33,724 shares of NRIX, which is worth approximately $743,614. The most recent transaction as insider was on Nov 01, 2024, when has been sold 3,546 shares (Common Stock) at a price of $24.28 per share, resulting in proceeds of $86,096. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.7K
33.88% 3M change
60.96% 12M change
Total Value Held $743,614

Hans van Houte Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2024
SELL
Open market or private sale
$86,096 $24.28 p/Share
3,546 Reduced 9.51%
33,724 Common Stock
Oct 30 2024
SELL
Open market or private sale
$57,542 $24.3 p/Share
2,368 Reduced 5.97%
37,270 Common Stock
Oct 30 2024
BUY
Exercise of conversion of derivative security
-
8,636 Added 17.89%
39,638 Common Stock
Aug 26 2024
SELL
Open market or private sale
$504,400 $25.22 p/Share
20,000 Reduced 39.21%
31,002 Common Stock
Aug 01 2024
SELL
Open market or private sale
$75,902 $21.83 p/Share
3,477 Reduced 6.38%
51,002 Common Stock
Jul 30 2024
SELL
Open market or private sale
$51,468 $20.67 p/Share
2,490 Reduced 4.37%
54,479 Common Stock
Jul 30 2024
BUY
Exercise of conversion of derivative security
-
8,636 Added 13.16%
56,969 Common Stock
Jun 20 2024
SELL
Open market or private sale
$400,200 $20.01 p/Share
20,000 Reduced 29.27%
48,333 Common Stock
May 02 2024
SELL
Open market or private sale
$44,892 $12.83 p/Share
3,499 Reduced 4.87%
68,333 Common Stock
Apr 30 2024
SELL
Open market or private sale
$16,699 $12.04 p/Share
1,387 Reduced 1.89%
71,832 Common Stock
Apr 30 2024
BUY
Exercise of conversion of derivative security
-
4,886 Added 6.26%
73,219 Common Stock
Feb 16 2024
SELL
Open market or private sale
$68,256 $10.02 p/Share
6,812 Reduced 9.07%
68,333 Common Stock
Jan 30 2024
SELL
Open market or private sale
$13,351 $7.99 p/Share
1,671 Reduced 2.18%
75,145 Common Stock
Jan 30 2024
BUY
Exercise of conversion of derivative security
-
4,886 Added 5.98%
76,816 Common Stock
Dec 20 2023
SELL
Open market or private sale
$35,410 $10.0 p/Share
3,541 Reduced 4.69%
71,930 Common Stock
Dec 19 2023
SELL
Open market or private sale
$109,060 $10.0 p/Share
10,906 Reduced 12.63%
75,471 Common Stock
Oct 31 2023
SELL
Open market or private sale
$5,616 $5.2 p/Share
1,080 Reduced 1.23%
86,377 Common Stock
Oct 30 2023
BUY
Exercise of conversion of derivative security
-
4,886 Added 5.29%
87,457 Common Stock
Jul 31 2023
SELL
Open market or private sale
$12,014 $9.65 p/Share
1,245 Reduced 1.49%
82,571 Common Stock
Jul 30 2023
BUY
Exercise of conversion of derivative security
-
4,886 Added 5.51%
83,816 Common Stock
May 01 2023
SELL
Open market or private sale
$7,123 $9.88 p/Share
721 Reduced 0.91%
78,930 Common Stock
Apr 30 2023
BUY
Exercise of conversion of derivative security
-
2,886 Added 3.5%
79,651 Common Stock
Jan 30 2023
SELL
Open market or private sale
$10,884 $11.78 p/Share
924 Reduced 1.19%
76,765 Common Stock
Jan 30 2023
BUY
Exercise of conversion of derivative security
-
2,886 Added 3.58%
77,689 Common Stock
Oct 31 2022
SELL
Open market or private sale
$9,518 $12.88 p/Share
739 Reduced 0.98%
74,803 Common Stock
HvH

Hans Van Houte

Chief Financial Officer
San Francisco, CA

Track Institutional and Insider Activities on NRIX

Follow Nurix Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

News

Receive news related to Nurix Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NRIX